$0 Understanding and Managing Polypharmacy — Quick-Start Checklist

Nursing Home Polypharmacy: What Families Should Watch For

Nursing Home Polypharmacy: What Families Should Watch For

Your parent moved into a nursing home three months ago. At admission, they were on seven medications. Now they're on twelve. A sleep aid was added because they weren't sleeping well in the new environment. An antipsychotic appeared after they became agitated during a staffing shortage. A laxative was prescribed to counter the constipation caused by the new pain medication. Nobody asked whether the original seven were still appropriate.

Polypharmacy in nursing homes follows a predictable pattern: medications are added reactively but rarely reassessed, and the institutional setting creates unique pressures that drive pill counts higher than community-dwelling seniors experience.

Why Nursing Homes Have Higher Medication Counts

The average nursing home resident takes nine or more medications daily. Several structural factors drive this:

Consultant physicians rotate. Unlike a primary care doctor who sees your parent regularly, nursing home medical directors and consultant physicians may see residents monthly or less. They review charts, respond to staff reports, and prescribe — often without the context of how the resident actually looks and functions day to day.

Staff report symptoms, not causes. When your parent becomes restless at night, nursing staff document "sleep disturbance" and the physician prescribes a sedative. The underlying cause — untreated pain, a noisy roommate, medication side effects — goes uninvestigated because the immediate problem is managed pharmacologically.

Regulatory pressure cuts both ways. CMS requires nursing homes to provide adequate treatment, creating liability risk if a treatable condition goes unmedicated. But CMS also requires unnecessary drug reduction through the Unnecessary Medication regulation (F-tag 757). In practice, the pressure to treat usually wins over the pressure to simplify.

The Antipsychotic Problem

Antipsychotic medications in nursing homes deserve special attention. These drugs — quetiapine, risperidone, olanzapine, haloperidine — carry FDA black box warnings about increased mortality risk in elderly patients with dementia. Despite this, they're prescribed to manage behavioral symptoms like agitation, wandering, and sundowning.

CMS tracks antipsychotic use as a quality measure. The national average hovers around 14% of long-stay residents, but individual facilities range from under 5% to over 30%. You can check any facility's rate on Medicare's Care Compare website.

If your parent has been started on an antipsychotic, ask three questions:

  1. What specific behavior prompted this prescription?
  2. Were non-pharmacological interventions tried first (and documented)?
  3. Is there a planned gradual dose reduction date?

Federal regulations require that antipsychotics prescribed for behavioral symptoms must have a documented gradual dose reduction attempted within the first year, unless clinically contraindicated. If the facility can't show you this plan, that's a red flag.

Your Rights to Medication Review

Federal law gives nursing home residents (and their legal representatives) specific medication-related rights:

Monthly drug regimen review. Every nursing home must have a consultant pharmacist who reviews each resident's complete medication regimen at least monthly. This review should identify unnecessary drugs, inappropriate doses, adverse reactions, and potential interactions. The pharmacist reports findings to the attending physician, who must act on them within a set timeframe.

Access to medication records. You have the right to see your parent's complete medication administration record (MAR), which documents every drug given, the time administered, and any PRN (as-needed) medications used. Request this monthly — patterns in PRN use often reveal undertreated symptoms or emerging side effects.

Care plan participation. Federal regulations guarantee your right to participate in care planning meetings, which must address the medication regimen. These meetings happen at admission, quarterly, and after any significant change in condition.

Right to refuse medications. Your parent (or their authorized representative) can refuse any medication. If the facility pressures you about refusal, they're violating federal regulations.

Free Download

Get the Understanding and Managing Polypharmacy — Quick-Start Checklist

Everything in this article as a printable checklist — plus action plans and reference guides you can start using today.

How to Advocate for Medication Reduction

Step one is getting the full picture. Request a printed copy of your parent's current medication list, including PRN orders. Compare it against the list from admission. Flag every medication that was added after admission and ask what triggered each one.

Step two is engaging the consultant pharmacist directly. You can request a meeting with the pharmacist who performs the monthly drug regimen reviews. Ask them specifically about:

  • Medications on the Beers Criteria or STOPP/START lists
  • Any prescribing cascades (one drug treating the side effect of another)
  • Opportunities for deprescribing — stopping medications where the risks now outweigh the benefits

Step three is documenting your concerns formally. Put medication concerns in writing to the director of nursing and attending physician. Written requests create a regulatory paper trail that facilities take more seriously than verbal conversations.

If the facility is unresponsive, every state has a Long-Term Care Ombudsman program that advocates for nursing home residents. They can investigate medication concerns and mediate between families and facilities.

Monitoring Between Visits

You can't be at the nursing home every day, but you can set up systems:

  • Request weekly PRN reports — a spike in as-needed pain or anxiety medication often signals an undertreated problem or a new drug side effect
  • Track weight monthly — unexplained weight loss can indicate medication-related appetite suppression or GI problems
  • Watch for new falls — any fall should trigger a medication review, specifically checking for fall-risk-increasing drugs
  • Note behavioral changes after medication changes — increased drowsiness, confusion, or agitation within days of a new prescription is a side effect until proven otherwise

The Understanding and Managing Polypharmacy toolkit includes a medication dossier worksheet and deprescribing conversation scripts designed for exactly this situation — giving you the clinical language to have productive conversations with nursing home physicians and pharmacists.

Get Your Free Understanding and Managing Polypharmacy — Quick-Start Checklist

Download the Understanding and Managing Polypharmacy — Quick-Start Checklist — a printable guide with checklists, scripts, and action plans you can start using today.

Learn More →